176 related articles for article (PubMed ID: 37777966)
1. Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity.
Yuan M; Feng Z; Lv H; So N; Shen IR; Tan TJC; Teo QW; Ouyang WO; Talmage L; Wilson IA; Wu NC
Cell Rep; 2023 Oct; 42(10):113194. PubMed ID: 37777966
[TBL] [Abstract][Full Text] [Related]
2. Widespread impact of immunoglobulin V gene allelic polymorphisms on antibody reactivity.
Yuan M; Feng Z; Lv H; So N; Shen IR; Tan TJC; WenTeo Q; Ouyang WO; Talmage L; Wilson IA; Wu NC
bioRxiv; 2023 Jun; ():. PubMed ID: 37333077
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.
Pushparaj P; Nicoletto A; Sheward DJ; Das H; Castro Dopico X; Perez Vidakovics L; Hanke L; Chernyshev M; Narang S; Kim S; Fischbach J; Ekström S; McInerney G; Hällberg BM; Murrell B; Corcoran M; Karlsson Hedestam GB
Immunity; 2023 Jan; 56(1):193-206.e7. PubMed ID: 36574772
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
[TBL] [Abstract][Full Text] [Related]
5. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.
Staudt LM; Gerhard W
J Exp Med; 1983 Feb; 157(2):687-704. PubMed ID: 6600489
[TBL] [Abstract][Full Text] [Related]
6. Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V
Lang S; Xie J; Zhu X; Wu NC; Lerner RA; Wilson IA
Cell Rep; 2017 Sep; 20(12):2935-2943. PubMed ID: 28930686
[TBL] [Abstract][Full Text] [Related]
7. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
[TBL] [Abstract][Full Text] [Related]
8. [Genetic bases of antibody diversity].
Baranov OK; Eppel' MS
Genetika; 1984 Sep; 20(9):1397-413. PubMed ID: 6437904
[TBL] [Abstract][Full Text] [Related]
9. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
Lingwood D; McTamney PM; Yassine HM; Whittle JR; Guo X; Boyington JC; Wei CJ; Nabel GJ
Nature; 2012 Sep; 489(7417):566-70. PubMed ID: 22932267
[TBL] [Abstract][Full Text] [Related]
10. IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity.
de Mattos Barbosa MG; Liu H; Huynh D; Shelley G; Keller ET; Emmer BT; Sherman E; Ginsburg D; Kennedy AA; Tai AW; Wobus C; Mirabeli C; Lanigan TM; Samaniego M; Meng W; Rosenfeld AM; Prak ETL; Platt JL; Cascalho M
JCI Insight; 2021 May; 6(9):. PubMed ID: 33769311
[TBL] [Abstract][Full Text] [Related]
11. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
Yuan T; Li J; Zhang MY
MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
[TBL] [Abstract][Full Text] [Related]
12. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.
Schmidt AG; Xu H; Khan AR; O'Donnell T; Khurana S; King LR; Manischewitz J; Golding H; Suphaphiphat P; Carfi A; Settembre EC; Dormitzer PR; Kepler TB; Zhang R; Moody MA; Haynes BF; Liao HX; Shaw DE; Harrison SC
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):264-9. PubMed ID: 23175789
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain.
Chai M; Guo Y; Yang L; Li J; Liu S; Chen L; Shen Y; Yang Y; Wang Y; Xu L; Yu C
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35362510
[TBL] [Abstract][Full Text] [Related]
14. IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.
Avnir Y; Watson CT; Glanville J; Peterson EC; Tallarico AS; Bennett AS; Qin K; Fu Y; Huang CY; Beigel JH; Breden F; Zhu Q; Marasco WA
Sci Rep; 2016 Feb; 6():20842. PubMed ID: 26880249
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families.
Clarke SH; Claflin JL; Potter M; Rudikoff S
J Exp Med; 1983 Jan; 157(1):98-113. PubMed ID: 6401319
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Kreer C; Zehner M; Weber T; Ercanoglu MS; Gieselmann L; Rohde C; Halwe S; Korenkov M; Schommers P; Vanshylla K; Di Cristanziano V; Janicki H; Brinker R; Ashurov A; Krähling V; Kupke A; Cohen-Dvashi H; Koch M; Eckert JM; Lederer S; Pfeifer N; Wolf T; Vehreschild MJGT; Wendtner C; Diskin R; Gruell H; Becker S; Klein F
Cell; 2020 Aug; 182(4):843-854.e12. PubMed ID: 32673567
[TBL] [Abstract][Full Text] [Related]
18. Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance.
Verkoczy L; Diaz M; Holl TM; Ouyang YB; Bouton-Verville H; Alam SM; Liao HX; Kelsoe G; Haynes BF
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):181-6. PubMed ID: 20018688
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture.
Malisheni MM; Bates M; Rizvanov AA; MacAry PA
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558771
[TBL] [Abstract][Full Text] [Related]
20. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
